☆ 4.5 Review

Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms

PATHOGENS (2022)

Related references

Note: Only part of the references are listed.

Letter Medicine, General & Internal

Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study

Raul Mendez et al.

JOURNAL OF INTERNAL MEDICINE (2022)

Add to Collection

Article Respiratory System

Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS

Nicola Latronico et al.

Summary: This study reported on the outcomes of 114 COVID-19-associated ARDS survivors evaluated at 3, 6, and 12 months after discharge from the ICU, showing persisting impairment in physical function, while activities of daily living, cognitive and mental health status, and health-related quality of life may be less impaired. The study found improvements in handgrip dynamometry and cognitive impairment over time, but 6 min walk test, severe fatigue, depression, anxiety, and post-traumatic stress disorder symptoms did not show significant improvements.

THORAX (2022)

Add to Collection

Article Immunology

Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study

Jessica Seessle et al.

Summary: Long COVID, defined as persistent symptoms after SARS-CoV-2 infection, can last for at least 1 year and significantly impact life quality. Neurocognitive symptoms, possibly related to autoimmunity indicated by elevated ANA titers, are more common in females and can persist even when SARS-CoV-2 antibody levels are not significantly different from patients without symptoms.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China

Tingting Liu et al.

Summary: This study investigated longitudinal changes in the characteristics of COVID-19 survivors after discharge. Physiological, laboratory, radiological, or electrocardiogram abnormalities, particularly those related to renal, cardiovascular, and liver functions are common in patients who recovered from COVID-19 up to 12 months post-discharge. Symptoms decreased over time, but abnormalities in certain health indicators persisted.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset

Elke Wynberg et al.

Summary: The study reveals that post-COVID syndrome is common, especially in mild cases. Female and obese participants tend to recover more slowly, regardless of age or comorbidities.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Virology

Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission

Ignacio Perez Catalan et al.

Summary: This study analyzed the long-term symptoms of COVID-19 patients and found that treatment with corticosteroids during the acute phase may attenuate the presence of long-term symptoms and improve patients' quality of life.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study

Lorenzo Gamberini et al.

Summary: The study found that HRQoL among COVID-19 ICU survivors improved within one year after discharge, especially in the physical dimensions, while the mental dimensions and dyspnea remained stable. Four main 15D profiles were identified, with about 47.2% of patients achieving full recovery and about 58.4% experiencing persistent dyspnea.

RESPIRATORY MEDICINE (2021)

Add to Collection

Article Respiratory System

Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study

Cesar Fernandez-de-las-Penas et al.

Summary: This study investigated the prevalence of post-COVID-19 cough one year after hospital discharge in COVID-19 survivors and found that a significant proportion of patients still experienced respiratory symptoms post-discharge, with a 2.5% prevalence of long-term cough. No clear risk factors associated with long-term post-COVID-19 cough were identified.

LUNG (2021)

Add to Collection

Article Medicine, General & Internal

Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China

Xue Zhang et al.

Summary: This study found that patients with severe disease during hospitalization for COVID-19 had more post-infection symptoms and higher CAT scores at 1-year follow-up. Older age, female sex, and severe disease were identified as risk factors for fatigue, while severe disease and older age were associated with having at least 3 symptoms.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Critical Care Medicine

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study

Xiaojun Wu et al.

Summary: Most patients recovering from severe COVID-19 showed improvement in dyspnoea scores and exercise capacity over time, but a subgroup of patients still exhibited persistent physiological and radiographic changes at 12 months post-discharge. A unified pathway for respiratory follow-up is needed for COVID-19 patients.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Review Medicine, General & Internal

Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis

Cesar Fernandez-de-las-Penas et al.

Summary: This meta-analysis revealed that more than 60% of patients with SARS-CoV-2 infection experienced post-COVID-19 symptoms. Fatigue and dyspnea were the most prevalent post-COVID-19 symptoms, especially at 60 and >= 90 days after onset.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up

Viviana Maestrini et al.

Summary: This prospective study aimed to evaluate the occurrence of cardiovascular disease (CVD) in hospitalized COVID-19 patients and its impact on clinical outcomes. The results showed a high prevalence of CVD (28%) in COVID-19 patients, with acute myocarditis being the most common. Patients with CVD had a higher risk of in-hospital mortality, emphasizing the importance of cardiovascular evaluation and treatment in COVID-19 patients. Follow-up assessments at one month and one year also revealed a significant proportion of patients with persistent or delayed CVD symptoms, highlighting the need for monitoring COVID-19 survivors for long-term cardiovascular complications.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Article Infectious Diseases

Follow-up study on COVID-19 survivors one year after discharge from hospital

Yumiao Zhao et al.

Summary: This study evaluated the long-term consequences of COVID-19 survivors one year after recovery, finding that survivors were mainly troubled with muscle fatigue and insomnia. It also revealed high prevalence of pulmonary structural abnormalities and pulmonary diffusion capacities in COVID-19 patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

One-year mortality and consequences of COVID-19 in cancer patients: A cohort study

Chen Chai et al.

Summary: This study found that COVID-19 patients with cancer have significantly higher 1-year mortality rates compared to non-cancer patients, but the long-term mortality rate of surviving cancer COVID-19 patients is similar to that of cancer patients. Different tumor subtypes have different effects on COVID-19 outcomes.

IUBMB LIFE (2021)

Add to Collection

Article Medicine, General & Internal

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

Lixue Huang et al.

LANCET (2021)

Add to Collection

Article Otorhinolaryngology

High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation

P. Boscolo-Rizzo et al.

RHINOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Add to Collection

Editorial Material Otorhinolaryngology

Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19)

Paolo Boscolo-Rizzo et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge

Modesto M. Maestre-Muniz et al.

Summary: The study investigated post-acute health consequences and mortality one year after hospital discharge among survivors of acute COVID-19. The findings revealed a 7.5% mortality rate among survivors and a significant proportion experiencing ongoing symptoms 1 year after disease onset.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms

Andreas Rank et al.

Summary: This study found that some patients with mild COVID-19 may still experience persistent symptoms one year later, but these symptoms gradually decrease over time. Specific antibodies can still be detected 12 months later, with antibody levels decreasing within the first 6 months but remaining stable up to 12 months.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection

Yan Zhan et al.

Summary: Long-term immunity and functional recovery are observed in COVID-19 survivors, with high seroprevalence and stable total antibodies. However, decreased levels of specific antibodies and neutralization against variants pose a risk, especially for severe patients with lingering symptoms and organ involvement.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Characterising long COVID: a living systematic review

Melina Michelen et al.

Summary: Long COVID is a complex condition with prolonged and heterogeneous symptoms, including weakness, general malaise, fatigue, concentration impairment, and breathlessness. Approximately 37% of patients reported reduced quality of life, and 26% of studies presented evidence of reduced pulmonary function. There is an urgent need for further studies to explore the etiology, risk factors, and biomarkers of long COVID in different populations and settings.

BMJ GLOBAL HEALTH (2021)

Add to Collection

Article Psychiatry

The WHO-5 Well-Being Index: A Systematic Review of the Literature

Christian Winther Topp et al.

PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)

Add to Collection

Article Psychology, Clinical

The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation

Christy A. Blevins et al.

JOURNAL OF TRAUMATIC STRESS (2015)

Add to Collection

Article Health Care Sciences & Services

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data

Zachary Munn et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Metaprop: a Stata command to perform meta-analysis of binomial data

Victoria N. Nyaga et al.

ARCHIVES OF PUBLIC HEALTH (2014)

Add to Collection

Article Economics

The Development and Validation of a Multidimensional Sum-Scaling Questionnaire to Measure Patient-Reported Outcomes in Acute Respiratory Tract Infections in Primary Care: The Acute Respiratory Tract Infection Questionnaire

Rune Aabenhus et al.

VALUE IN HEALTH (2013)

Add to Collection

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Add to Collection

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Add to Collection

Article Clinical Neurology

Validation of the Insomnia Severity Index as an outcome measure for insomnia research

Celyne H. Bastien et al.

SLEEP MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.